Opportunity Information: Apply for RFA OD 13 004
Apply for RFA OD 13 004
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Lasker Clinical Research Scholars Program (Si2)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.140 Intramural Research Training Award.
- This funding opportunity was created on Mar 8, 2013 and posted on Mar 8, 2013.
- Applicants must submit their applications by Jun 24, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 5 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Other Eligible Applicants include the following Applications will be submitted directly by the individual PD/PI, not from an organization. Eligible Individuals (Program Director/Principal Investigator) Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Eligible applicants include physicians and dentists (including MD, MD/PhD, DO, DDS, DMD, RN/PhD, or equivalent clinical doctoral degree from an accredited domestic or foreign institution) and must have a professional license to practice medicine or dentistry in the U.S. The program is intended for investigators at the early stages of their careers. At the time the application for the initial IRP phase is submitted, applicants must be no more than 10 years from completion of their core residency training. Applicants will generally have completed or be completing a post residency clinical fellowship, and will have demonstrated sufficient patient oriented research experience to qualify for a tenure track level appointment. Applicants do not have to be U.S. citizens or permanent residents, although selected Scholars must qualify for and maintain appropriate visa/residency status throughout the program. In order to be eligible to compete for a special Lasker Scholars Grant to receive the extramural award in the second phase of the program, the candidate must successfully compete and have obtained a full time appointment at a U.S. academic institution.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Lasker Clinical Research Scholars Program (Si2) is a National Institutes of Health (NIH) funding opportunity designed to help early-career clinical researchers launch and sustain independent, patient-oriented research programs. It is built specifically to create a bridge between the NIH Intramural Research Program (research conducted within NIH) and the broader extramural research world (research conducted at universities, hospitals, and other external institutions). The core idea is to give promising clinician-scientists a structured runway into independence, with significant protected time, resources, and a pathway that can continue either inside NIH or at a U.S. academic institution.
The program is organized into two phases. In Phase 1, selected Lasker Scholars receive a tenure-track appointment within the NIH Intramural Research Program for up to 5 to 7 years, along with an independent research budget. This phase is meant to support scholars as they establish themselves as independent investigators, build a research team, and develop a strong clinical research portfolio within NIH’s intramural environment. In Phase 2, scholars who are successful in the intramural phase can pursue continued NIH support for up to an additional 5 years to conduct their research at an extramural research facility, typically a U.S. academic institution. Alternatively, depending on circumstances and review outcomes, a scholar may be considered to remain as an investigator within the NIH intramural program rather than transitioning to an external institution. This two-phase structure is a defining feature of the opportunity and is intended to make the transition between intramural and extramural research careers more feasible and less risky for clinician-investigators.
Eligibility is centered on individual applicants rather than organizations, meaning applications are submitted directly by the proposed Program Director/Principal Investigator (PD/PI). The opportunity targets clinicians with doctoral-level clinical degrees, including physicians and dentists (such as MD, MD/PhD, DO, DDS, DMD, RN/PhD, or an equivalent clinical doctoral degree from an accredited U.S. or foreign institution). Applicants must also hold a professional license to practice medicine or dentistry in the United States. The program is aimed at investigators in the early stages of their careers; at the time of applying for the initial intramural phase, applicants must be no more than 10 years from completion of core residency training. Applicants typically will have completed or be completing a post-residency clinical fellowship and should already have enough patient-oriented research experience to be competitive for a tenure-track level appointment. U.S. citizenship or permanent residency is not required to apply, but anyone selected must be able to obtain and maintain the appropriate visa or residency status for the full duration of participation. For Phase 2 specifically, to compete for the extramural Lasker Scholars Grant, the scholar must successfully obtain a full-time appointment at a U.S. academic institution.
From an administrative standpoint, this opportunity was released by NIH as a discretionary grant program under Funding Opportunity Number RFA-OD-13-004, with a funding activity category tied to education and health. The program anticipated making about five awards. It is listed under CFDA 93.140 (Intramural Research Training Award) and does not require cost sharing or matching. The posting date was March 8, 2013, with an original and current closing date of June 24, 2013, and an archive date of July 25, 2013. The full announcement and official details were made available through the NIH Grants Guide, and applicants needing technical assistance were directed to the NIH Office of Extramural Research (OER) webmaster contacts.
Overall, the Lasker Clinical Research Scholars Program is best understood as a career-shaping NIH initiative for clinician-scientists who are ready to lead independent clinical research early in their careers. It combines the stability and resources of an NIH intramural tenure-track start with a built-in option to compete for continued NIH support in an extramural setting, effectively offering a structured, competitive pathway to long-term independence in clinical and translational research.
Frequently Asked Questions (FAQs): Lasker Clinical Research Scholars Program (Si2)
What is the Lasker Clinical Research Scholars Program (Si2)?
The Lasker Clinical Research Scholars Program (Si2) is a National Institutes of Health (NIH) funding opportunity intended to help early-career clinical researchers launch and sustain independent, patient-oriented research programs.
What is the main purpose of this program?
The program is designed to create a bridge between NIH's Intramural Research Program (research conducted within NIH) and the extramural research world (research conducted at universities, hospitals, and other external institutions). It aims to provide a structured pathway for clinician-scientists to reach research independence.
How is the program structured?
The program has two phases: an initial intramural phase at NIH (Phase 1) and a potential extramural phase at an external U.S. academic institution (Phase 2), with the possibility in some cases of remaining within NIH instead of transitioning externally.
What happens in Phase 1?
In Phase 1, selected Lasker Scholars receive a tenure-track appointment within the NIH Intramural Research Program for up to 5 to 7 years, along with an independent research budget. This phase supports scholars as they establish an independent research program, build a team, and develop a clinical research portfolio within NIH.
How long does Phase 1 last?
Phase 1 can last up to 5 to 7 years.
What happens in Phase 2?
In Phase 2, scholars who are successful in Phase 1 can pursue continued NIH support for up to an additional 5 years to conduct research at an extramural research facility, typically a U.S. academic institution.
How long does Phase 2 last?
Phase 2 can provide NIH support for up to an additional 5 years.
Is transitioning to an external institution required for Phase 2?
Not always. Depending on circumstances and review outcomes, a scholar may be considered to remain as an investigator within the NIH intramural program rather than transitioning to an external institution.
Who submits the application: an institution or an individual?
Eligibility is centered on individual applicants rather than organizations. Applications are submitted directly by the proposed Program Director/Principal Investigator (PD/PI).
Who is the program intended for?
The program targets early-career clinician-scientists who are ready to lead independent, patient-oriented clinical research and who can be competitive for a tenure-track level appointment.
What types of degrees are eligible?
Eligible applicants include clinicians with doctoral-level clinical degrees, such as MD, MD/PhD, DO, DDS, DMD, RN/PhD, or an equivalent clinical doctoral degree from an accredited U.S. or foreign institution.
Is a U.S. professional license required?
Yes. Applicants must hold a professional license to practice medicine or dentistry in the United States.
How is "early-career" defined for this opportunity?
At the time of applying for the initial intramural phase (Phase 1), applicants must be no more than 10 years from completion of core residency training.
Do applicants need to have fellowship training?
Applicants typically will have completed or be completing a post-residency clinical fellowship.
Do applicants need prior research experience?
Yes. Applicants should already have enough patient-oriented research experience to be competitive for a tenure-track level appointment.
Is U.S. citizenship or permanent residency required to apply?
No. U.S. citizenship or permanent residency is not required to apply.
If selected, are there immigration or visa requirements?
Yes. Anyone selected must be able to obtain and maintain the appropriate visa or residency status for the full duration of participation.
What is required to compete for Phase 2 (the extramural Lasker Scholars Grant)?
To compete for Phase 2 support, the scholar must successfully obtain a full-time appointment at a U.S. academic institution.
What kind of research does the program support?
It is intended to support independent, patient-oriented research programs led by clinician-scientists.
What is the Funding Opportunity Number for this program?
The NIH Funding Opportunity Number listed for this program is RFA-OD-13-004.
How many awards were anticipated?
The program anticipated making about five awards.
Is cost sharing or matching required?
No. The opportunity does not require cost sharing or matching.
What is the CFDA number associated with this opportunity?
The opportunity is listed under CFDA 93.140 (Intramural Research Training Award).
When was this opportunity posted and when did it close?
The posting date was March 8, 2013. The original and current closing date was June 24, 2013. The archive date was July 25, 2013.
Where were the official details published?
The full announcement and official details were made available through the NIH Grants Guide.
Where could applicants get technical assistance for this opportunity?
Applicants needing technical assistance were directed to the NIH Office of Extramural Research (OER) webmaster contacts.
Browse more opportunities from the same category: Education Health
Next opportunity: Gut Microbiome Brain Interactions and Mental Health (R21/R33)
Previous opportunity: Great Lakes Restoration Initiative Grants to Support Great Lakes State Aquatic Invasive/Nuisance Species Management Plans
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA OD 13 004
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA OD 13 004) also looked into and applied for these:
| Funding Opportunity |
|---|
| Limited Competition Multicenter AIDS Cohort Study Center for the Coordination, Analysis, and Management of the MACS (CAMACS)(UM1) Apply for RFA AI 13 010 Funding Number: RFA AI 13 010 Agency: National Institutes of Health Category: Education Health Funding Amount: $2,400,000 |
| Limited Competition Multicenter AIDS Cohort Study (MACS) Clinical Research Sites (U01) Apply for RFA AI 13 011 Funding Number: RFA AI 13 011 Agency: National Institutes of Health Category: Education Health Funding Amount: $4,200,000 |
| Limited Competition Scholars Training for the Advancement of Research (STAR) Revision to NINR T32 Training Grants (T32) Apply for RFA NR 13 010 Funding Number: RFA NR 13 010 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NCI Exploratory/Developmental Research Grant Program (NCI Omnibus R21) Apply for PAR 13 146 Funding Number: PAR 13 146 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Advancing Exceptional Research on HIV/AIDS (R01) Apply for RFA DA 14 003 Funding Number: RFA DA 14 003 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R21) Apply for PA 13 157 Funding Number: PA 13 157 Agency: National Institutes of Health Category: Education Health Funding Amount: $175,000 |
| Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R21/R33) Apply for PAR 13 158 Funding Number: PAR 13 158 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NIDA Mentored Clinical Scientists Development Program Award in Drug Abuse and Addiction (K12) Apply for PAR 13 163 Funding Number: PAR 13 163 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Innovative Research Methods Prevention and Management of Symptoms in Chronic Illness (R01) Apply for PA 13 165 Funding Number: PA 13 165 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| Innovative Research Methods Prevention and Management of Symptoms in Chronic Illness (R15) Apply for PA 13 166 Funding Number: PA 13 166 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Innovative Research Methods Prevention and Management of Symptoms in Chronic Illness (R21) Apply for PA 13 167 Funding Number: PA 13 167 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| The Role of Microbial Metabolites in Cancer Prevention and Etiology (U01) Apply for PAR 13 159 Funding Number: PAR 13 159 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Academic Industrial Partnerships for Translation of in vivo Imaging Systems for Cancer Investigations (R01) Apply for PAR 13 169 Funding Number: PAR 13 169 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Drug Abuse Dissertation Research (R36) Apply for PAR 13 182 Funding Number: PAR 13 182 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Collaborative Research in Integrative Cancer Biology (U01) Apply for PAR 13 184 Funding Number: PAR 13 184 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Image guided Drug Delivery in Cancer (R01) Apply for PAR 13 185 Funding Number: PAR 13 185 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Eradication of HIV 1 from CNS Reservoirs Implications for Therapeutics (R01) Apply for RFA MH 14 170 Funding Number: RFA MH 14 170 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Eradication of HIV 1 from CNS Reservoirs Implications for Therapeutics (R21) Apply for RFA MH 14 171 Funding Number: RFA MH 14 171 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Detection of Pathogen Induced Cancer (DPIC) (R01) Apply for PAR 13 190 Funding Number: PAR 13 190 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Revision Applications to U01 Awards for Research on Imaging and Biomarkers for Early Cancer Detection (U01) Apply for PAR 13 176 Funding Number: PAR 13 176 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA OD 13 004", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
